Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,692 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05711173Recruiting
Study blood clot triggers and immune cell changes in clot patients
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
BordeauxAges 6–50 - NCT05712785Recruiting
Ureteroscopy test for stones in the ureter
This trial studies ureteroscopy, a procedure where a camera and tools are used through the urethra to reach and treat ureter stones. It may help people whose kidney/urine tract stones are causing symptoms and who can safely cooperate with treatment.
Handan, HebeiAges 18–85 - NCT05713214Recruiting
Long-term follow-up after a gene-modified cell treatment
This study checks long-term health after receiving a gene-modified cell therapy through a St. Jude study. It helps doctors understand the treatment’s lasting effects and safety over time.
Memphis, TennesseeAges Any age - NCT05713123Recruiting
Test of a new camera for iodine 131 thyroid cancer imaging
This study compares two types of scanning cameras to see how well they record images in people with thyroid cancer treated with iodine 131. It may help improve which camera gives clearer results after this treatment.
Vandœuvre-lès-NancyAges 18 years+ - NCT05713734Recruiting
Study of unexplained bleeding blood tests in adults
This Swiss study looks at people with unexplained bleeding by using a standardized bleeding score and taking a blood sample. It may help researchers better understand possible bleeding causes even when the reason isn’t clear yet.
BellinzonaAges 16–65 - NCT05713903Recruiting
Compare keyhole versus open surgery for right colon cancer
This trial compares two surgical approaches—keyhole surgery versus open surgery—for right colon cancer. It aims to see which approach works better and is safer for patients needing planned (elective) tumor removal.
LarissaAges 18–90 - NCT05714917Recruiting
Studying recovery after nerve damage from NOS use
This study looks at how neurological symptoms (like numbness, weakness, unsteadiness, or walking problems) recover after damage caused by NOS use. It may help researchers understand what recovery looks like and what support or treatments could work best.
BirminghamAges 16–40 - NCT05715710Recruiting
MRI and brain vein pattern study for memory and thinking problems
This study looks at whether certain deep brain veins seen on MRI are linked to thinking and memory problems in people with small-vessel brain disease. It compares brain scan findings with cognitive (thinking) testing to better understand what may drive cognitive dysfunction.
Zigong, SichuanAges 50–85 - NCT05717738Recruiting
Immunotherapy plus targeted drugs after TACE for liver cancer
This trial tests a combination of blood-vessel–targeting medicine and immunotherapy after a liver-directed treatment called TACE for advanced hepatocellular carcinoma (HCC). It aims to control tumor growth when surgery or ablation isn’t suitable, and to see if this “conversion therapy” helps patients do better than standard pathways.
Quanzhou, FujianAges 18 years+ - NCT05717790Recruiting
Nimotuzumab with chemo and radiation for advanced nose cancer
This trial tests whether adding nimotuzumab (an anti-EGFR antibody) to standard chemotherapy and radiation can improve outcomes for people with advanced nasopharyngeal carcinoma. It may help the cancer respond better and control it more effectively after treatment.
Baise City, GuangxiAges 18–70 - NCT05718128RecruitingPhase 4
Study of taking heart muscle samples from the inside
This trial studies patients who need an endocardial myocardial biopsy, meaning a small heart muscle sample taken from inside the heart. It’s meant for people with heart problems whose cause is not clearly known and may help doctors learn more about what’s going on.
Hangzhou, ZhejiangAges 18–80 - NCT05718622Recruiting
EECP for people with stable first stroke and blocked artery
This study looks at whether EECP (a non-surgical therapy that helps blood flow) improves outcomes in people who recently had their first ischemic stroke and have a narrowed or blocked artery. It also aims to predict who may benefit most based on health data.
Xi'an, ShaanxiAges 18–80 - NCT05719415Recruiting
Testing balloon treatment effects on lung blood-vessel surface area
This study looks at how a procedure called balloon pulmonary angioplasty changes measurements in lung blood vessels in people with chronic thromboembolic pulmonary hypertension. It may help doctors understand what changes the treatment makes and why.
Montreal, QuebecAges 18–75 - NCT05719467RecruitingPhase 3
Safety check of medicine to start labor
This Phase 3 study tests the safety of a medicine used to help start labor (“induction”). It may help by aiming for a safer, smoother induction process for people who are ready to deliver and meet specific pregnancy and health criteria.
LørenskogAges 18–50 - NCT05719844Recruiting
Computer tests to assess concussion recovery in young rugby players
This study checks whether a set of computer-based attention and thinking tests can help manage concussion (a brain injury) in young rugby players. It compares players who had a concussion with similarly aged players who haven’t had one.
Clermont-FerrandAges 11–25 - NCT05720260RecruitingPhase 2
Test immunotherapy plus hormone therapy and an AKT blocker
This trial tests whether combining immunotherapy, hormone therapy, and an AKT-blocking drug can control ER-positive advanced breast cancer in women whose cancer is resistant to hormone treatment. It may help shrink tumors and slow disease by targeting several pathways at once.
TaipeiAges 20 years+ - NCT05720936Recruiting
Nerve block treatment for dangerous heart rhythm episodes
This trial looks at a procedure called a stellate ganglion block to calm dangerous, repeated heart rhythm attacks that haven’t improved with standard medicines. It may help reduce how often and how long these episodes last while you’re in the hospital.
Alessandria, ALAges Any age - NCT05721599Recruiting
Nutrition and lifestyle counseling for older adults with diabetes
This trial tests whether a combined nutrition and lifestyle counseling program can improve health and daily functioning in frail older adults with type 2 diabetes. It may help by giving structured guidance to support safer, healthier routines.
Hualien CityAges 65 years+ - NCT05722405RecruitingPhase 4
Ixazomib plus lenalidomide compared to ixazomib alone for myeloma maintenance
This trial studies whether adding low-dose lenalidomide to ixazomib can help keep high-risk multiple myeloma from coming back after initial treatment. It may help prolong the time before the disease worsens, while also checking side effects.
Hangzhou, ZhejiangAges 18–80 - NCT05723445Recruiting
Low glycemic diet test for diabetes and body changes in CF
This trial studies whether a low glycemic load (a specific way of choosing carbohydrates) improves blood sugar control and body composition in adults with cystic fibrosis–related diabetes. It may help reduce blood sugar problems and support healthier weight and body measurements.
Boston, MassachusettsAges 18–70 - NCT05723471Recruiting
Physical activity program for newly diagnosed cancer patients
This trial studies whether a structured exercise (physical activity) program started soon after a new cancer diagnosis is safe and helpful. You may benefit if you can safely do activity and meet key health measures.
Nancy, FranceAges 18 years+ - NCT05724004Recruiting
Alectinib then targeted radiation for ALK-positive lung cancer
This trial tests giving alectinib first, then adding targeted radiation to remaining spots of cancer in people with ALK-rearranged advanced non-small cell lung cancer. It aims to control the cancer after an initial response and help keep disease from progressing.
StockholmAges 20 years+ - NCT05725174Recruiting
Study seizure signals using quick, non-invasive breath tests
This study looks for “volatile” (gaseous) body signals from breath to help identify seizure events. If you were recently admitted for seizure diagnosis, you may be asked to provide breath samples in a non-invasive way.
London, BuckinghamshireAges 18 years+ - NCT05725200RecruitingPhase 2
Personalized treatment plan for metastatic colon or rectal cancer
This Phase 2 trial tests an individualized treatment chosen from your tumor’s lab testing (genetic and RNA profile plus a drug-sensitivity test from your tumor cells). It may help by matching you to targeted anti-cancer drugs that are most likely to work for your specific cancer.
OsloAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,692 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.